Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 7 of the 13 calendar months from Oct 2025 to Oct 2026: Mar 2026, May 2026, Jun 2026, Jul 2026, Aug 2026, Sep 2026 and Oct 2026.
- Largest single sale: $480K (5,656 shares) of Oruka Therapeutics, Inc. on Jul 13, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | Senior Vice President, Finance | Sep 6, 2024 | Oct 13, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Oct 12, 2026, Oruka Therapeutics, Inc.: sold 9,999 shares for $806K, under a disclosed plan; 9,999 shares acquired by exercising options. 1 filing: 1
- Sep 21, 2026, Oruka Therapeutics, Inc.: sold 533 shares for $51K, under a disclosed plan. 1 filing: 1
- Sep 15, 2026, Oruka Therapeutics, Inc.: sold 560 shares for $54K, under a disclosed plan. 1 filing: 1
- Sep 11, 2026, Oruka Therapeutics, Inc.: sold 9,459 shares for $872K, under a disclosed plan; 9,459 shares acquired by exercising options. 1 filing: 1
- Aug 13, 2026, Oruka Therapeutics, Inc.: sold 10,000 shares for $1.1M, under a disclosed plan; 10,000 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.